Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer

被引：4
|
作者：
Pujade-Lauraine, Eric [1 ]
机构：
[1] Univ Paris 05, Hop Univ Paris Ctr, Unite Canc Femme & Rech Clin, F-75004 Paris, France
来源：
JOURNAL OF GYNECOLOGIC ONCOLOGY | 2013年 / 24卷 / 03期
关键词：
TRIAL;
D O I：
10.3802/jgo.2013.24.3.209
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：209 / 211
页数：3
相关论文
共 50 条
  • [31] Mirvetuximab Soravtansine for platinum-resistant Ovarian Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (08) : 882 - 882
  • [32] ECONOMIC BURDEN IN PLATINUM-RESISTANT OVARIAN CANCER
    Indukuri, Nikhila
    Musat, Mihaela
    Chavez, Gordon
    Proescholdt, Christina
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A142 - A142
  • [33] PATIENT REPORTED OUTCOME IN PLATINUM-RESISTANT RECURRENT OVARIAN CANCER AND METASTATIC BREAST CANCER TREATED WITH METRONOMIC CHEMOTHERAPY
    Krajnak, S.
    Battista, M.
    Almstedt, K.
    Anic, K.
    Heimes, A. S.
    Linz, V.
    Schwab, R.
    Hasenburg, A.
    Schmidt, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A196 - A196
  • [34] A source of hope for platinum-resistant ovarian cancer?
    Blagden, Sarah P.
    Nicum, Shibani
    LANCET, 2021, 397 (10271): : 254 - 256
  • [35] Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
    Gonzalez-Ochoa, Eduardo
    Veneziani, Ana C.
    Oza, Amit M.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2023, 17
  • [36] Topotecan in platinum-resistant epithelial ovarian cancer
    Karabulut, B
    Sezgin, C
    Terek, MC
    Uslu, R
    Sanli, UA
    Akman, L
    Ozsaran, A
    Dikmen, Y
    Goker, E
    CHEMOTHERAPY, 2005, 51 (06) : 347 - 351
  • [37] ATR Inhibitors in Platinum-Resistant Ovarian Cancer
    Li, Siyu
    Wang, Tao
    Fei, Xichang
    Zhang, Mingjun
    CANCERS, 2022, 14 (23)
  • [38] Treatment Approaches for Platinum-Resistant Ovarian Cancer
    St Laurent, Jessica
    Liu, Joyce F.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (02) : 127 - 133
  • [39] Update on Strategies for Platinum-Resistant Ovarian Cancer
    Pothuri, Bhavana
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (04) : 202 - 204
  • [40] Paclitaxel in platinum-resistant ovarian cancer patients
    Ezcurdia, L
    Jovtis, SL
    Mickiewicz, E
    Temperley, G
    Rondinon, M
    Blajman, C
    Coppola, FS
    Lewi, D
    Cazap, E
    Breier, S
    Fasce, H
    Fein, L
    Polera, J
    Triguboff, E
    Uranga, G
    Pasccon, G
    Luchina, AM
    Martinez, CA
    Politi, PM
    Rubio, G
    Alvarez, AM
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 53 - 56
12345